Our analysis revealed significant positive correlations between TLCD1 and drug sensitivity to fulvestrant, econazole nitrate, and amonafide, all of which are clinical drugs used in cancer treatment (Figure 7A). This evidence concerns the gene TLCD1 and cancer.